abstract |
The invention relates to polynucleotides targeted against a gene of a catalytic sub-unit of human telomerase and the use of said polynucleotides for the diagnosis, prophylaxis, reduction and course control of diseases linked to cell growth, differentiation and/or division, such as, for example, tumorous diseases. |